Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mohammad Gayoor Khan"'
Autor:
Hani Alothaid, Mohammed S. Aldughaim, Azeez Oriyomi Yusuf, Umama Yezdani, Alaa Alhazmi, Mahmoud M. Habibullah, Mohammad Gayoor Khan
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 2119-2126 (2021)
Albendazolum (ABZ) is a BCS class II drug. It has challenging biopharmaceutical properties, which include poor solubility and dissolution rate. These properties have laid the ground for developing a supersaturated self-nanoemulsifying drug delivery s
Externí odkaz:
https://doaj.org/article/4837e5bbf5534906b19573c605748185
Autor:
Ikechukwu Otuosorochi Amagwula, Chijioke M. Osuji, Chinenyenwa Gloria Omeire, Umama Yezdani, Mohammad Gayoor Khan, Chinaza Godswill Awuchi
Publikováno v:
Biogenesis: Jurnal Ilmiah Biologi. 10
Autor:
Mohammad Gayoor Khan, Hani Alothaid, Saad Saeed Alamri, Mahmoud Habibullah, Umama Yezdani, Mazen M. Ghaith
Publikováno v:
Case Reports in Clinical Medicine. 10:99-107
Background: Breast lymphomas are typical extranodal types of lymphoma, also known as Extranodal-lymphoma (ENL), which occur extremely infrequently, aggregating into a very small proportion of malignant breast tumors. The rarity of breast lymphomas is
Autor:
Mohammad Gayoor Khan, Aarti Singh Kushwah, Sabitha Mary Kurian, M Thangapandi, Veena Suresh, Umama Yezdani, D. Nagendra Babu
Publikováno v:
International Journal of Current Research and Review. 12:61-72
Autor:
Alaa Alhazmi, Mohammad Gayoor Khan, Mahmoud Habibullah, Azeez Yusuf, Umama Yezdani, Mohammed S. Aldughaim, Hani Alothaid
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 28, Iss 1, Pp 2119-2126 (2021)
article-version (VoR) Version of Record
Drug Delivery, Vol 28, Iss 1, Pp 2119-2126 (2021)
Albendazolum (ABZ) is a BCS class II drug. It has challenging biopharmaceutical properties, which include poor solubility and dissolution rate. These properties have laid the ground for developing a supersaturated self-nanoemulsifying drug delivery s
Autor:
Shourabh Rav, Shayam singh Maina, Rachna Malviya, Madan Gopal Kushwah, Mohammad Gayoor khan, Umama Yezdani
Publikováno v:
International Journal of Pharmaceutical Research and Development. 1:19-22
Publikováno v:
Bangladesh Journal of Medical Science.
The clinical range of Covid-19 is a respiratory route infection that varies from Asymptomatic to various clinical conditions such as respiratory failure to multiple organ dysfunction syndromes (MODS). Government administration officials are ramping u
Publikováno v:
SSRN Electronic Journal.
Obesity itself called Major disease in another term obesity is power house of the disease if the person is suffering obesity he/she might be near to very dangerous disease such as diabetes, high blood pressure, cholesterol, sickness, abnormal of horm
Autor:
Mohammad Gayoor Khan, Yezdani Umama, Hari Baskar, Kumar Ayush, Karthikeyan Lakshman, Monika Sekar
Psoriasis is an autoimmune condition which results in the body attacking itself. It occurs in the age group of 14 to ≥ 65 years. The average age is 28 years. More than 10 million cases per year in India are being recorded. Around 15% of cases emerg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::5a7be802602b84ee7900bc47f7329e29
https://zenodo.org/record/5482711
https://zenodo.org/record/5482711
Publikováno v:
SSRN Electronic Journal.
Novel Drug Delivery system is the New and advanced branch of Pharmaceutical branch in this field covered Nano Particles, Nanosomes, etc. This system is advanced & very easy to understand the Pharmacokinetic and Pharmacodynamic behavior of drug since,